Accelerated Approval or Risk Reduction? How Response...

  • Main
  • 2020 / 8
  • Accelerated Approval or Risk Reduction? How Response...
Trends in Molecular Medicine 2020 / 8

Accelerated Approval or Risk Reduction? How Response Biomarkers Advance Therapeutics through Clinical Trials in Cystic Fibrosis

Mayer-Hamblett, N., VanDevanter, D.R.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Journal:
Trends in Molecular Medicine
DOI:
10.1016/j.molmed.2020.08.002
Date:
August, 2020
File:
PDF, 752 KB
2020
Conversion to is in progress
Conversion to is failed